Global Radiopharmaceuticals in Nuclear Medicine Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Nuclear medicine : Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes. The Radiopharmaceuticals in Nuclear Medicine market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Radiopharmaceuticals in Nuclear Medicine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Radiopharmaceuticals in Nuclear Medicine Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Radiopharmaceuticals in Nuclear Medicine market are: Taiyo Nippon Sanso Corporation Nordion, Inc. Institute Of Radioelement (IRE) Institute of Atomic Energy Polatom Radioisotope Centre Fujifilm Holdings Corporation Ntp Radioisotopes (Pty), Ltd. Board of Radiation And Isotope Technology (BRIT) Cardinal Health, Inc. GE Healthcare (Subsidiary Of General Electric Company) Eczacibasi-Monrol Bracco Imaging S.P.A. Australian Nuclear Association And Technology Organization (ANSTO) Institute of Isotopes Co., Ltd. Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. IBA Group Rotem Industries, Ltd., Inc. Siemens Healthcare (Subsidiary Of Siemens AG) Urenco Limited Cambridge Isotope Laboratories, Inc. Covidien, Plc Most important types of Radiopharmaceuticals in Nuclear Medicine products covered in this report are: Diagnostic Nuclear Medicine Therapeutic Nuclear Medicine Others Most widely used downstream fields of Radiopharmaceuticals in Nuclear Medicine market covered in this report are: Hospitals Specialty Clinics Diagnostic Centers Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.